11.07.2015 Views

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

He<strong>al</strong>th Technology Assessment 1997; Vol. 1: No. 4Tsai MS, Chien TY, Yang YL, Chen HR, Hwang SM,1995. Identification of the number of the fragile-Xsyndrome CGG repeat using silver stain. Am J HumanGen<strong>et</strong>ics;57:1941.Tsong<strong>al</strong>is GJ, Silverman LM, 1993. Molecular pathologyof the fragile X syndrome [review]. Arch Path LabMed;117:1121–5.Turk J, 1992a. The fragile X syndrome: recentdevelopments. Curr Opin Psych;2:677–82.Turk J, 1992b. The fragile-X syndrome. On theway to a behaviour<strong>al</strong> phenotype [review].Br J Psych;160:24–35.Turk J, 1995a. <strong>Fragile</strong> X syndrome. Arch Dis Child;72:3–5.Turk J, 1995b. The psychiatric, psychologic<strong>al</strong> andbehaviour<strong>al</strong> functioning of a British sample of boyswith the fragile X syndrome [MD thesis]. Universityof London.Turk J, 1995c. Treatment of fragile-X syndrome.Arch Dis Child;72:544.Turner G,1996. Intelligence and the X chromosome.Lanc<strong>et</strong>;347:1814–15.Turner G, Turner B, 1974. X-linked ment<strong>al</strong> r<strong>et</strong>ardation.J Med Gen<strong>et</strong>ics;11:109–13.Turner G, Daniel A, Frost M, 1980. X-linked ment<strong>al</strong>r<strong>et</strong>ardation, macro-orchidism, and the Xq27 fragilesite. J Ped;96:837–41.Turner G, Robinson H, Laing S, Purvis-Smith S, 1986.Preventative screening <strong>for</strong> the fragile X syndrome.N Engl J Med;315:607–9.Turner G, Robinson H, Laing S, <strong>et</strong> <strong>al</strong>, 1992. Populationscreening <strong>for</strong> fragile X. Lanc<strong>et</strong>;339:1210–13.Turner AM, Robinson H, Wake S, Laing SJ, Leigh D,Turner G, 1994a. Counselling risk figures <strong>for</strong> fragileX carrier fem<strong>al</strong>es of varying band sizes <strong>for</strong> use inpredicting the likelihood of r<strong>et</strong>ardation in theiroffspring. Am J Med Gen<strong>et</strong>ics;51:458–62.Turner G, Robinson H, Wake S, Martin N, 1994b.Dizygous twinning and premature menopause infragile X syndrome. Lanc<strong>et</strong>;344:1500.Turner G, Webb T, Wake S, Robinson H, 1996.Prev<strong>al</strong>ence of fragile-x syndrome. Am J MedGen<strong>et</strong>ics;64:196–7.Väisänen ML, Kähkönen M, Leisti J, 1994. Diagnosisof fragile X syndrome by direct mutation an<strong>al</strong>ysis.Human Gen<strong>et</strong>ics;93:143–7.van den Ouweland AM, Deelen WH, Kunst CB, <strong>et</strong> <strong>al</strong>,1994a. Loss of mutation at the FMR1 locus throughmultiple exchanges b<strong>et</strong>ween matern<strong>al</strong> X chromosomes.Human Molec Gen<strong>et</strong>ics;3:1823–7.van den Ouweland AM, de Vries BB, Bakker PL, <strong>et</strong> <strong>al</strong>,1994b. DNA diagnosis of the fragile X syndrome in aseries of 236 ment<strong>al</strong>ly r<strong>et</strong>arded subjects and evidence<strong>for</strong> a revers<strong>al</strong> of mutation in the FMR-1 gene.Am J Med Gen<strong>et</strong>ics;51:482–5.Verheij C, Bakker CE, de Graaff E, <strong>et</strong> <strong>al</strong>, 1993.Characterization and loc<strong>al</strong>ization of the FMR-1gene product associated with fragile X syndrome.Nature;363:722–4.Verheij C, de Graaff E, Bakker CE, <strong>et</strong> <strong>al</strong>, 1995. Characterisationof FMR1 proteins isolated from different tissues.Human Molec Gen<strong>et</strong>ics;4:895–901.Verkerk AJ, Pier<strong>et</strong>ti M, Sutcliffe JS, <strong>et</strong> <strong>al</strong>, 1991. Identificationof a gene (FMR-1) containing a CGG repeatcoincident with a breakpoint cluster region exhibitinglength variation in fragile X syndrome. Cell;65:905–14.Verkerk AJMH, de Vries BBA, Niermeijer MF, <strong>et</strong> <strong>al</strong>,1992. Intragenic probe used <strong>for</strong> diagnostics in fragileX families. Am J Med Gen<strong>et</strong>ics;43:192–6.Vianna-Morgante AM, Otto PA. Notes on thepopulation gen<strong>et</strong>ics of fragile X syndrome.Am J Med Gen<strong>et</strong>ics;43:339–44.Vieregge P, Froster-Iskenius U, 1989. Clinico-neurologic<strong>al</strong>investigations in the fraX <strong>for</strong>m of ment<strong>al</strong> r<strong>et</strong>ardation.J Neurol;236:85–92.Vits L, De Boulle K, Reyniers E, <strong>et</strong> <strong>al</strong>, 1994. Apparentregression of the CGG repeat in FMR1 to an <strong>al</strong>lele ofnorm<strong>al</strong> size. Human Gen<strong>et</strong>ics;94:523–6.von Koskull H, Gahmberg N, S<strong>al</strong>onen R, S<strong>al</strong>o A,Peippo M, 1994. FRAXA locus in fragile X diagnosis:family studies, prenat<strong>al</strong> diagnosis, and diagnosis ofsporadic cases of ment<strong>al</strong> r<strong>et</strong>ardation. Am J MedGen<strong>et</strong>ics;51:486–9.Wake SA, Robinson H, 1995. Assessment of counselingof norm<strong>al</strong> m<strong>al</strong>es and norm<strong>al</strong> transmitting m<strong>al</strong>ecarriers identified in fragile-X families. Dev BrainDysfunction;8:319–26.Wang Q, Green E, Barnicoat A, <strong>et</strong> <strong>al</strong>, 1993. Cytogen<strong>et</strong>icversus DNA diagnosis in routine referr<strong>al</strong>s <strong>for</strong> fragile Xsyndrome. Lanc<strong>et</strong>;342:1025–6.Wang Q, Green E, Bobrow M, Mathew CG, 1995a.A rapid, non-radioactive screening test <strong>for</strong> fragileX mutations at the FRAXA and FRAXE loci. J MedGen<strong>et</strong>ics;32:170–3.Wang Q, Green E, Bobrow M, Mathew CG, 1995b.<strong>Screening</strong> <strong>for</strong> the fragile X A and E mutations byautomated fluorescent an<strong>al</strong>ysis. J Med Gen<strong>et</strong>ics;32:153.Watkiss E, Webb T, 1995. Comparison of m<strong>et</strong>hods<strong>for</strong> studying X inactivation status in fem<strong>al</strong>es. J MedGen<strong>et</strong>ics;32:151.Watson MS, Leckman JF, Annex B, <strong>et</strong> <strong>al</strong>, 1984. <strong>Fragile</strong>X in a survey of 75 autistic m<strong>al</strong>es [l<strong>et</strong>ter]. N Engl JMed;310:1462.Webb GC, Rogers JG, Pitt DB, H<strong>al</strong>liday J, Theob<strong>al</strong>d T,1981. Transmission of fragile (X) (q27) site from am<strong>al</strong>e [l<strong>et</strong>ter]. Lanc<strong>et</strong>;ii:1231–2.Webb J, 1993. A fragile case <strong>for</strong> screening.New Sci;140:10–11.67

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!